Skip to content

Success for Biotech Company

20 December 2016

INDOOR Biotechnologies

A biotech company that began life as an incubator business at Cardiff’s Medicentre is about to graduate.

Indoor Biotechnologies specializes in innovative products and services for indoor air quality, environmental sciences, allergy and asthma.

The company’s products help detect the causes of allergies, including those from pollen, food, animals and mites.

Launched four years ago, Indoor has grown to a seven-strong team of immunology scientists researching and developing new products.

The company will be moving to new lab and office space in the east of Cardiff – a process known as graduation.

Dr James Hindley, Executive Director of Indoor said, “Our time at Cardiff Medicentre has put us in the best possible position to enter phase two of Indoor’s development.

“The support we have had from the Medicentre team and their contacts has enabled us to establish a strong presence within Europe and beyond. We have made some really valuable connections with local researchers, government representatives, and professional service providers, and we have also been able to recruit some exceptional talent from within South Wales.”

Dr James Hindley, Executive Director, Indoor Biotechnologies

Trading in more than 50 countries, and with turnover expected to stand at £1.4m for 2016 – 90% of which from exports – Indoor Biotechnologies is considered to be one of the leading global providers of products and services in the field of allergy, and opened a new facility in India earlier this year.

The company’s graduation comes at a significant time for Cardiff Medicentre. The first incubator of its kind in the UK, the centre is looking ahead to its 25th anniversary.

Robyn Davies, Manager at Cardiff Medicentre, said, “Success stories are in plentiful supply at the Medicentre, and this latest development is a very proud moment for us. It is always so rewarding to see our tenants graduate out of incubation, and we wish James and his team all the very best for the future.”

Cardiff Medicentre is now under the ownership of major shareholder Cardiff University, and Cardiff & Vale University Health Board.

Share this story

Meet the engaged innovators using cutting-edge research to produce benefits for the economy, society and the environment.